FindTrial
Sign In

To evaluate the specific blood parameters in blistering skin disorders and compare it with the healthy population

Assessment of immuno-metabolic axis of Autoimmune Blistering Diseases (AIBDs) – Mechanistic and diagnostic implications - nil

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/03/064871
Enrollment
42
Registered
2024-03-28
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L100- Pemphigus vulgaris

Interventions

Intervention1: nil: nil Control Intervention1: nil: nil

Sponsors

Indian Association of Dermatologists Venereologists and Leprologists (IADVL)
Lead Sponsor
Department of Dermatology Kasturba medical college Manipal
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: All new cases of Pemphigus (and its variants) and Pemphigoid group of diseases diagnosed by immunofluorescence studies(DIF/IIF) or serological methods.

Exclusion criteria

Exclusion criteria: a. Patients unwilling to give consent for the study or investigations. b. Patients who are in remission.

Design outcomes

Secondary

MeasureTime frame
to study the difference between the cytokine & metabolomic profile of pemphigus & pemphigoid group of conditionsTimepoint: over a period of 2 years—

Primary

MeasureTime frame
to study the difference between cytokine and metabolomic profiles of patients with autoimmune blistering disorders with that of control groupTimepoint: at first presentation to the principle investigator—

Countries

India

Contacts

Public ContactDr Raghavendra Rao

Kasturba Medical College Manipal

jenny.rao@manipal.edu9845292640

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026